Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
Authors not listed
The Jackson Laboratory · 2017
Abstract
This is a prospective, single-site, randomized, then open-label study designed to develop a detailed transcriptional and epigenetic profile of the immune response to pneumococcal vaccination with conjugated and non-conjugated polysaccharide vaccines in the senescent immune system of older adults.
In this study, 40 healthy adults ages 60 and older that have never received pneumococcal vaccination, will be randomized in a 1:1 ratio to receive Prevnar-13 (Pfizer), a conjugated 13-valent vaccine or Pneumovax 23 (Merck), a non-conjugated 23-valent vaccine. Following randomized assignment of vaccine, the study will be open-label.
Six (6) study visits will occur over about 70 days, with an optional 7th visit for participants to receive a second vaccination with the other pneumococcal vaccine one to two years after randomization. Participants will provide blood samples for transcriptional, epigenetic and biological analyses pre- and post-vaccination.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Anonymous. (2017). Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines. <em>The Jackson Laboratory</em>. https://clinicaltrials.gov/study/NCT03104075
Vancouver
Anonymous. Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines. The Jackson Laboratory. 2017.
BibTeX
@misc{anon2017Genomi,
title = {Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines},
author = {Anonymous},
journal = {The Jackson Laboratory},
year = {2017},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
UConn Health 2019
Open access · US-GOV
Vaccination Efficacy With Metformin in Older Adults: A Pilot Study
The University of Texas Health Science Center at San Antonio 2019
Open access · US-GOV
Metformin and Vaccine Response in Older Adults
Charles Raison 2026
Open access · US-GOV
An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life
Vanderbilt University 2010
Open access · US-GOV
Evaluation of Cell-mediated Immunity and Antibody Response to Influenza Vaccination and Correlates of Protection in Seniors
University of South Florida 2011
Open access · US-GOV
Phase II Study of a Nutraceutical on the Cognitive Performance of Older Adults.
Cell Metabolism 2024
Open access · OA